chr2-111123885-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_138621.5(BCL2L11):āc.140A>Gā(p.Asn47Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000234 in 1,609,046 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_138621.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BCL2L11 | NM_138621.5 | c.140A>G | p.Asn47Ser | missense_variant | 2/4 | ENST00000393256.8 | NP_619527.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BCL2L11 | ENST00000393256.8 | c.140A>G | p.Asn47Ser | missense_variant | 2/4 | 1 | NM_138621.5 | ENSP00000376943 | P1 | |
MIR4435-2HG | ENST00000645030.2 | n.453-86963T>C | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152196Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000608 AC: 15AN: 246606Hom.: 0 AF XY: 0.0000450 AC XY: 6AN XY: 133474
GnomAD4 exome AF: 0.000253 AC: 369AN: 1456732Hom.: 0 Cov.: 33 AF XY: 0.000250 AC XY: 181AN XY: 724712
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152314Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74474
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 06, 2022 | The c.140A>G (p.N47S) alteration is located in exon 2 (coding exon 1) of the BCL2L11 gene. This alteration results from a A to G substitution at nucleotide position 140, causing the asparagine (N) at amino acid position 47 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at